Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

7 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

HIS talk after biopsy breast cancer - HIS

- 20/09/2021 - 1 Formulaire, 4 Groupes Item, 44 Eléments de données, 2 Langues
Groupes Item: Patientenaufkleber groß, Patienteninformation, geplante Operation, Patienteninformation II
documentation standard - breast cancer - gynecology, with friendly permission (Dr. Tio) - kooperatives Brustzentrum Münster, Bereich Senologie an der Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe - Leitung: Dr. med. Joke Tio

HIS cancer conference after biopsy breast cancer - HIS

- 15/05/2013 - 1 Formulaire, 10 Groupes Item, 69 Eléments de données, 2 Langues
Groupes Item: Patientenaufkleber groß, Tumorkonferenz, Angaben zum Patienten, Verlauf, Pathologie Befund, Fragestellung, Subformular, MDT (MIB), Aktion, Empfehlungen der Tumorkonferenz
HIS cancer conference after biopsy breast cancer

Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162 - Best overall response assessment; New tumor biopsy/ sample (Report Final and Annex Report 2 Final)

- 30/10/2020 - 1 Formulaire, 3 Groupes Item, 29 Eléments de données, 1 Langue
Groupes Item: Administrative, Best overall response assessment, New tumor biopsy/ sample
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma

Effects of Low-fat and high-fat meals on the Pharmacokinetics of Lapatinib in ErB2+ Breast Cancer patients, NCT00821054 - Liver biopsy

- 09/01/2021 - 1 Formulaire, 15 Groupes Item, 158 Eléments de données, 1 Langue
Groupes Item: Administrative Data, Date of liver biopsy, Liver Biopsy size, Liver Biopsy Final Diagnosis, Liver Architecture, Description of Liver Cells or Hepatocytes, Liver Cell or Hepatocyte Inclusions or Vacuoles, Hepatocyte or Liver Cell Nuclear Abnormalities, Liver or Lobular Infiltrates, Portal Tract Inflammation, Bile Ducts, Portal Veins, Liver Infections, Liver: Parasites or Ova, Histologic Staining or Additional Studies Obtained
Study ID: 111582 Clinical Study ID: 111582 Study Title: An Open Label Study to Examine the Effects of Low-fat and High-fat Meals on the Pharmacokinetics of Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00821054 https://clinicaltrials.gov/ct2/show/NCT00821054 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Lapatinib Trade Name: N/A Study Indication: Neoplasms, Breast The study consists of a screening, four study visits at day-1, week 1, 2 and 3 and a follow-up visit. This document is supposed to document the results of a possible liver biopsy.

HIS pathology report - biopsy prostate cancer - HIS

- 07/08/2013 - 1 Formulaire, 6 Groupes Item, 40 Eléments de données, 2 Langues
Groupes Item: Admininstrative Daten, Tumorhistologie, Histologie, Stanzen, Stanze, Lokalisation von Fernmetastasen
HIS form from Soarian. Urologie Erlangen" with friendly permission of the urology Erlangen (Prof. Wullich) and the medical informatics department Erlangen (PD Dr. Bürkle)

HIS pathology report - biopsy prostate cancer - HIS

- 15/05/2013 - 1 Formulaire, 6 Groupes Item, 39 Eléments de données, 2 Langues
Groupes Item: Admininstrative Daten, Tumorhistologie, Histologie, Stanzen, Stanze, Lokalisation von Fernmetastasen
HIS pathology report - biopsy prostate cancer

Eligibility Prostate Cancer NCT02375035

- 19/04/2020 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02375035

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial